Literature DB >> 27450283

Growth rate of vestibular schwannoma.

Iddo Paldor1, Annie S Chen2, Andrew H Kaye3.   

Abstract

Vestibular schwannoma (VS) is the most common tumor in the extra-axial posterior fossa compartment in adults. Growth rate is paramount to decision making regarding treatment and follow up of these tumors. We conducted a comprehensive review of the literature to answer four questions: What percentage of newly diagnosed VS will grow on follow-up? What factors correlate to tumor growth? What is the "normal" growth rate for sporadic VS? What factors characterize VS with rapid growth? Thirty-seven reports, with more than 4000 patients, fit our review criteria. One third of newly diagnosed VS will grow on follow-up of 1-3years. However, after 5years, up to one half will grow. Patient age and sex do not influence growth of VS. Hearing loss and vertigo at presentation do not predict tumor growth. It is unclear whether balance disturbance or tinnitus predict tumor growth. Tumor size and location do not predict tumor growth. Growth in the first year of observation is a strong predictor of tumor growth. The average growth rate of a VS is 0.99-1.11mm/year. However, the expected growth rate for VS that have been shown to grow at first follow-up is 3mm/year. Factors that may predict tumor growth of above 4mm/year are cystic and hemorrhagic features in the tumor, and hormonal treatment. VS grow at an average 1mm/year. VS that have been shown to grow at first follow-up should be considered for treatment, unless contraindicated. Long term follow-up is recommended for VS.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acoustic neuroma; Growth; Growth rate; Sporadic; Vestibular schwannoma

Mesh:

Year:  2016        PMID: 27450283     DOI: 10.1016/j.jocn.2016.05.003

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  24 in total

1.  Pretreatment ADC Values Predict Response to Radiosurgery in Vestibular Schwannomas.

Authors:  A Camargo; T Schneider; L Liu; J Pakpoor; L Kleinberg; D M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

2.  Tinnitus Management in Lateral Skull Base Lesions.

Authors:  Juan San Juan; Gregory J Basura
Journal:  J Neurol Surg B Skull Base       Date:  2018-11-30

3.  Medical Malpractice of Vestibular Schwannoma: A 40-Year Review of the United States Legal Databases.

Authors:  Jack Birkenbeuel; Kimberly Vu; Brandon M Lehrich; Mehdi Abouzari; Dillon Cheung; Pooya Khosravi; Ronald Sahyouni; Kasra Ziai; Omid Moshtaghi; Sammy Sahyouni; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2019-03       Impact factor: 2.311

4.  Growth rate and fate of untreated hemangioblastomas: clinical assessment of the experience of a single institution.

Authors:  Joonho Byun; Hee Jun Yoo; Jeong Hoon Kim; Young Hoon Kim; Young Hyun Cho; Seok Ho Hong; Chang Jin Kim
Journal:  J Neurooncol       Date:  2019-06-14       Impact factor: 4.130

Review 5.  Neuromonitoring of the cochlear nerve during vestibular schwannoma resection and simultaneous cochlear implantation.

Authors:  Nora M Weiss; Wilma Großmann; Sebastian P Schraven; Tobias Oberhoffner; Robert Mlynski
Journal:  HNO       Date:  2021-05-21       Impact factor: 1.284

6.  A standardised pathway for the surveillance of stable vestibular schwannoma.

Authors:  J Shapey; K Barkas; S Connor; A Hitchings; H Cheetham; S Thomson; J M U-King-Im; R Beaney; D Jiang; S Barazi; R Obholzer; Nwm Thomas
Journal:  Ann R Coll Surg Engl       Date:  2018-03       Impact factor: 1.891

Review 7.  [Neuromonitoring of the cochlear nerve during vestibular schwannoma resection and simultaneous cochlear implantation. German version].

Authors:  Nora M Weiss; Wilma Großmann; Sebastian Schraven; Tobias Oberhoffner; Robert Mlynski
Journal:  HNO       Date:  2021-03-17       Impact factor: 1.284

8.  The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma.

Authors:  Iddo Paldor; Sara Abbadi; Nicolas Bonne; Xiaobu Ye; Fausto J Rodriguez; David Rowshanshad; MariaLisa Itzoe; Veronica Vigilar; Marco Giovannini; Henry Brem; Jaishri O Blakeley; Betty M Tyler
Journal:  J Neurooncol       Date:  2017-07-22       Impact factor: 4.130

9.  EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Authors:  Roland Goldbrunner; Michael Weller; Jean Regis; Morten Lund-Johansen; Pantelis Stavrinou; David Reuss; D Gareth Evans; Florence Lefranc; Kita Sallabanda; Andrea Falini; Patrick Axon; Olivier Sterkers; Laura Fariselli; Wolfgang Wick; Joerg-Christian Tonn
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

10.  Defining current practice patterns of vestibular schwannoma management in Italy: results of a nationwide survey.

Authors:  Diego Cazzador; Elisabetta Zanoletti; Nicola Quaranta; Marco Pontrelli; Sabino Ciprelli; Francesco Signorelli; Luca Denaro; Domenico d'Avella; Giovanni Danesi
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.